-
Jefferies Downgrades Inari Medical Inc. (NARI) to Hold
-
BofA Securities Reiterates Buy Rating on Stryker (SYK)
-
Inari Medical Inc. (NARI) PT Raised to $80 at Piper Sandler Following Acquisition Agreement with Stryker (SYK)
-
Inari Medical, Inc. (NARI) call put ratio 5.4 calls to 1 put into Stryker (SYK) announcing into entered into a definitive agreement to acquire Inari in cash for $80 per share
-
Baird Downgrades Inari Medical Inc. (NARI) to Neutral
-
Canaccord Genuity Downgrades Inari Medical Inc. (NARI) to Hold
-
Evercore ISI Reiterates Outperform Rating on Stryker (SYK)
-
Stifel on Inari Medical Inc. (NARI): 'Quick Thoughts on the Deal and PEN Implications'
-
After-hours movers: Ulta Beauty, Inari Medical, Meta Platforms and more
-
Stryker (SYK) to acquire Inari Medical (NARI) for $80 Per Share, $4.9 Billion
-
Stryker (SYK) Nearing A Deal To Buy Inari Medical (NARI) , Sources Say - Reuters
-
Inari Medical, Inc. (NARI) halted on volatility
-
Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'
-
Oppenheimer Starts Inari Medical Inc. (NARI) at Outperform
-
Inari Medical, Inc. (NARI) Shareholder Notice: Grabar Law Office Is Investigating Claims on Your Behalf
-
Inari Medical (NARI) Named as New Short at Off Wall Street
-
BTIG Reiterates Buy Rating on Inari Medical Inc. (NARI)
-
Inari Medical (NARI) Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
-
Canaccord Genuity Reiterates Buy Rating on Inari Medical Inc. (NARI)
-
Inari Medical Inc. (NARI) PT Raised to $52 at Piper Sandler
-
Inari Medical Inc. (NARI) PT Raised to $67 at Baird
-
Inari Medical Inc. (NARI) PT Raised to $74 at Canaccord Genuity
-
Inari Medical Inc. (NARI) PT Raised to $50 at Truist Securities
-
BTIG Reiterates Buy Rating on Inari Medical Inc. (NARI)
-
Inari Medical, Inc. (NARI) Misses Q3 EPS by 19c, provides guidance
-
Inari Medical Inc. (NARI) PT Raised to $66 at Baird
-
Needham Reiterates Hold Rating on Inari Medical Inc. (NARI)
-
Stifel Starts Inari Medical Inc. (NARI) at Hold
-
Piper Sandler Reiterates Neutral Rating on Inari Medical Inc. (NARI)
-
Deutsche Bank Reiterates Buy Rating on Inari Medical Inc. (NARI)
-
Piper Sandler Reiterates Neutral Rating on Inari Medical Inc. (NARI)
-
Deutsche Bank Starts Inari Medical Inc. (NARI) at Buy
-
Inari Medical Inc. (NARI) PT Lowered to $55 at Truist Securities
-
Inari Medical Inc. (NARI) PT Raised to $71 at Canaccord Genuity
-
Inari Medical, Inc. (NARI) Misses Q2 EPS by 35c; offers guidance
-
Inari Medical, Inc. (NARI) Announces CFO Retirement
-
William Blair Starts Inari Medical Inc. (NARI) at Outperform
-
Needham Downgrades Inari Medical Inc. (NARI) to Hold
-
Inari Medical Inc. (NARI) PT Raised to $60 at Truist Securities
-
Inari Medical Inc. (NARI) PT Raised to $65 at Baird

